Manufacturer record
Rednex Pharmaceuticals Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
8 batches manufactured by Rednex Pharmaceuticals Pvt. Ltd (Kerala) were declared Not of Standard Quality between May 2025 and April 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
8 records linked to Rednex Pharmaceuticals Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Bromhexine Hydrochloride,Terbutaline Sulphate,Guaiphenesin & Menthol Syrup | R02GL2529Mfg 2025-01 · Exp 2026-12 | The sample does not conform to claim as per Manufacturer method & specification in respect to the Assay of MentholAssay | CDL, KolkataCDSCO lab | Apr 2026 |
| Chlorpheniramine Maleate, Dextromethorphan Hydrobromide & Phenylephrine Hydrochloride Syrup | R02GL2520Mfg 2025-02 · Exp 2027-01 | The sample does not conform to claim as per Schedule V, Drugs & Cosmetics Act in respect to the Assay of Dextromethorphan HydrobromideAssay | CDL, KolkataCDSCO lab | Feb 2026 |
| Bromhexine Hydrochloride,Terbutaline Sulphate,Guaiphenesin & Menthol Syrup | R12GL2424Mfg 2024-12 · Exp 2026-11 | The sample does not conform to claim as per Schedule V, Drugs & Cosmetics Act in respect to the Assay of MentholAssay | CDL, KolkataCDSCO lab | Jan 2026 |
| Bromhexine Hydrochloride,Terbutaline Sulphate,Guaiphenesin & Menthol Syrup | R01GL2522Mfg 2025-01 · Exp 2026-12 | The sample does not conform to claim as per Manufacturer method & specification in respect to the Assay of MentholAssay | CDL, KolkataCDSCO lab | Jan 2026 |
| Luliconazole Lotion IP 1% W/V LUZORAN Lotion 30ml | R09GE2518BMfg 2025-09 · Exp 2027-08 | The sample received does not conform to I.P. 2022 with respect to The test for Related substance.Related substances | CDTL, MumbaiCDSCO lab | Dec 2025 |
| Itraconazole Capsules BP 200 mg | R08GC2506AMfg 2025-08 · Exp 2027-07 | The sample received does not conform to I.P. 2022 with respect to The test for Dissolution.Dissolution | CDTL, MumbaiCDSCO lab | Dec 2025 |
| Bromhexine Hydrochloride,Terbutaline Sulphate,Guaiphenesin & Menthol Syrup Respifresh-TR | R12GL2426Mfg 2024-12 · Exp 2026-11 | The sample does not conform to claim as per Schedule V, Drugs & Cosmetics Act in respect to The Assay of Menthol.Assay | CDL, KolkataCDSCO lab | Dec 2025 |
| Sulcralfate& Oxetacaine Suspension( Piracid-O Suspension) | R05GL2423AMfg 2024-05 · Exp 2026-04 | Assay for Oxetacaine OnlyAssay | KarnatakaState lab | May 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.